• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthDigital Health

Chinese Doctor Who Created Gene-Edited Embryos Is Sentenced to Three Years in Prison

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
December 30, 2019, 3:05 PM ET

He Jiankui shocked the world in 2018 when he revealed that he’d used CRISPR technology, or gene editing, on babies—the first such application in history. Now, a Chinese court has sentenced him to three years in prison and a $430,000 fine for the controversial experiment, which is considered illegal since it involves CRISPR gene editing in reproduction, according to China’s Xinhua news agency.

He and associates allegedly carried out gene-editing experiments on embryos that led to the birth of three gene-edited “CRISPR babies.” Zhang Renli and Qin Jinzhou were also sentenced to more than two years in prison, albeit with a reprieve, in the case.

The process was meant to prevent these babies from being infected with HIV from a parent—though the scientific community including CRISPR pioneers Jennifer Doudna and Feng Zhang, along with drug makers, widely condemned the experiment.

It’s unclear how these babies are currently doing, though there have been no reports of adverse events.

A district court in Shenzhen ruled that He and his partners had conducted the embryonic gene-editing experiments “in the pursuit of personal fame and gain” and have seriously “disrupted medical order.” He’s partners

He has previously defended his efforts, even saying that he was “proud” of the results.

In Fortune‘s recent list of 25 ideas which will shape the 2020s, Doudna—a University of California at Berkeley professor and executive director of the Innovative Genomics Institute—addressed the ethical controversies that still dog gene editing, including He’s actions.

“I certainly hope that over the coming decade we see an increasing global effort to put in place appropriate regulations for using genome editing, especially in applications that could have a very profound impact on everyone,” she told Fortune.

Gene editing has been hailed for its potential to help treat diseases like cancer and sickle cell anemia. But the technology remains in its earliest stages. And as this case shows, ethical questions remain a significant concern.

More must-read stories from Fortune:

—25 ideas that will shape the 2020s
— Why there’s no room for your carry-on bags in the overhead bin
—UPS’s $20 billion bet on e-commerce is paying off
—Airbnb copes with a bad trip on the road to a 2020 IPO
—Electronic health records are creating a ‘new era’ of health care fraud
Subscribe to Fortune’s Eye on A.I. newsletter, where artificial intelligence meets industry.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

Latest in Health

Man checking watch as he walks through forrest
Successchief executive officer (CEO)
CEOs reveal their New Year’s resolutions for 2026: From 8-day bike races and AI training, to finally cracking 7 hours of sleep a night
By Emma BurleighDecember 24, 2025
16 hours ago
Best protein lead image
HealthDietary Supplements
The 9 Best Protein Powders of 2025: How to Choose, According to an RD
By Christina SnyderDecember 23, 2025
1 day ago
Transparent Labs Creatine HMB as best creatine
HealthDietary Supplements
The Best Creatine Supplements of 2025: Tested and Approved
By Christina SnyderDecember 23, 2025
1 day ago
HealthDietary Supplements
The Best Hair Loss Treatments of 2025: Tested and Approved by Experts
By Christina SnyderDecember 23, 2025
1 day ago
Hims Hair loss treatment
HealthDietary Supplements
Hims Hair Loss Review 2025: Pros, Cons, and More From Hands-On Testing
By Christina SnyderDecember 22, 2025
2 days ago
David Ko stands in front of a blue and purple "Fortune" background.
Healthchief executive officer (CEO)
The CEO behind the world’s top sleep and meditation app says most leaders are operating at ‘about 20%’ without a ‘fully recharged’ battery
By Sasha RogelbergDecember 19, 2025
6 days ago

Most Popular

placeholder alt text
Retail
Trump just declared Christmas Eve a national holiday. Here’s what’s open and closed
By Dave SmithDecember 24, 2025
14 hours ago
placeholder alt text
Personal Finance
Financial experts warn future winner of the $1.7 billion Powerball: Don't make these common money mistakes
By Ashley LutzDecember 23, 2025
1 day ago
placeholder alt text
Success
The average worker would need to save for 52 years to claw their way out of the middle class and be classified as wealthy, new research reveals
By Orianna Rosa RoyleDecember 23, 2025
1 day ago
placeholder alt text
Success
'When we got out of college, we had a job waiting for us': 80-year-old boomer says her generation left behind a different economy for her grandkids
By Mike Schneider and The Associated PressDecember 23, 2025
1 day ago
placeholder alt text
Law
Disgraced millennial Frank founder Charlie Javice hits JPMorgan with $74 million legal bill, including $530 in gummy bears and $347 'afternoon snack'
By Sasha RogelbergDecember 23, 2025
1 day ago
placeholder alt text
Economy
Obama's former top economic advisor says he feels 'a tiny bit bad' for Trump because gas prices are low, but consumer confidence is still plummeting 
By Sasha RogelbergDecember 24, 2025
7 hours ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.